Recently the FHIT gene (fragile histidine triad gene) has been identif
ied at chromosome 3p14.2 and a high frequency of abnormalities in this
gene has been demonstrated in various cancers, To determine the role
of the FHIT gene in leukaemia, bone marrow or peripheral blood from 62
acute myeloid leukaemia patients and five haemopoietic cell lines (HL
60, U937, Raji, KG-1, K562) were analysed by reverse transcription of
the FHIT mRNA followed by PCR amplification and sequencing of the prod
ucts, To detect the deletion of the FHIT gene, 17 cases were evaluated
using microsatellite polymorphism analysis. In this study, 17/62 (27%
) AML patients expressed aberrant transcripts which lack two or more e
xons of the FHIT gene, and all the cell lines exhibited the aberrant F
HIT transcripts. No cases exhibited a loss of the FHIT alleles, Our da
ta indicated that the FHIT gene may play a role in myeloid carcinogene
sis and may be indicated in the late progression of the disease.